 |
|
[Alpha Biz=(Chicago) Reporter Paul Lee] SK Group acquired the US bio company Proteovant Science through SK Biopharm and established a research base for finding new drug candidates there for the first time since its foundation.
Prior to this, SK Life Science established a clinical development and direct sales system in the United States. SK Farm Teco, a global pharmaceutical consignment development (CDMO) company, has its headquarters and production facilities in the United States.
SK Biopharm announced on the 30th that it will acquire a 60.0% stake in the US bio company Proteovant Science for 61.95325 billion won. The acquisition fund amounts to 19.6% of SK Biopharm's equity capital. The acquisition date of the stake is July 17th.
Proteovant Science is a joint venture (JV) co-founded by SK and Swiss-based bio company Roivant in March 2020. SK Biopharm secured a total of 60% of Roiband's stake and held a 100% stake with SK, which holds the remaining 40%.
AlphaBIZ 폴 리(hoondork1977@alphabiz.co.kr)
